Core Insights - The aquaculture sector experienced a rise of 0.72% on October 10, with Lihua Co. leading the gains [1] - The Shanghai Composite Index closed at 3897.03, down 0.94%, while the Shenzhen Component Index closed at 13355.42, down 2.7% [1] Aquaculture Sector Performance - Lihua Co. (300761) closed at 22.95, up 3.52% with a trading volume of 161,900 shares and a transaction value of 368 million yuan [1] - Other notable performers included: - Luoniushan (000735) at 6.49, up 3.34% [1] - Xiaoming Co. (300967) at 22.43, up 2.28% [1] - Minhe Co. (002234) at 8.57, up 2.15% [1] - The overall trading volume and transaction values for various stocks in the aquaculture sector were significant, indicating active market participation [1] Capital Flow Analysis - The aquaculture sector saw a net inflow of 134 million yuan from institutional investors, while retail investors experienced a net outflow of 1.31 billion yuan [2] - The main stocks with significant capital flow included: - Muyuan Foods (002714) with a net inflow of 199 million yuan from institutional investors [3] - Wens Foodstuff Group (300498) with a net inflow of 15.53 million yuan from institutional investors [3] - Retail investors showed a negative trend in net inflows across several stocks, indicating a cautious sentiment among smaller investors [2][3]

证券代码：603717 证券简称：天域生物 公告编号：2025-089 天域生物科技股份有限公司 关于收到《民事判决书》暨诉讼进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、本次诉讼的基本情况 天域生物科技股份有限公司（以下简称"公司"或者"原告"）为准确青海 聚之源新材料有限公司（以下简称"聚之源"或者"被告"）实际控制人刘炳生 先生三年期业绩承诺应补偿现金额事宜，于 2025 年 07 月向青海省德令哈市人民 法院提起股东知情权诉讼，诉请获得聚之源充分财务资料。具体内容详见公司于 2025 年 07 月 30 日在上海证券交易所官方网站（www.sse.com.cn）上披露的《关 1 案件所处的诉讼阶段：一审已判决 上市公司所处的当事人地位：原告 涉案的金额：暂无 是否会对上市公司损益产生负面影响：本次诉讼判决为一审判决，目前 尚未生效，诉讼最终结果等存在不确定性。本次诉讼旨在通过法律途径 行使股东知情权，诉请获得标的公司充分财务资料，准确核算三年期业 绩承诺应补偿现金额，以向刘炳生先生追偿三 ...

Core Viewpoint - Tianyu Biotechnology Co., Ltd. has received a first-instance civil judgment from the People's Court of Delingha City, Qinghai Province, regarding a lawsuit for shareholder information rights, aimed at obtaining financial data from the shareholder Ju Zhiyuan [1] Group 1 - The company filed a lawsuit in July 2025 to seek full financial information from Ju Zhiyuan, related to the calculation of performance compensation amounts [1] - The court ruled that Ju Zhiyuan must provide relevant financial reports, accounting books, and vouchers for Tianyu Biotechnology to review or copy within fifteen days from the effective date of the judgment [1] - Tianyu Biotechnology is allowed to engage intermediary agencies to assist in the review process, and the case acceptance fee will be borne by the defendant [1] Group 2 - The lawsuit aims to recover performance compensation; however, there is significant uncertainty regarding the realization of this compensation due to the poor financial condition of the compensator Liu Bingsheng and his outstanding debts [1] - The company advises investors to make cautious decisions and be aware of the associated risks [1]

Company Overview - Tianyu Biological Technology Co., Ltd. is located in Yangpu District, Shanghai, and was established on June 21, 2000, with its listing date on March 27, 2017 [2] - The company's main business includes landscape greening engineering design, construction and maintenance, municipal public engineering construction, environmental comprehensive governance, river and lake pollution control, soil pollution control, and seedling planting and sales [2] - The revenue composition of the main business is divided into segments: 281.96%, 114.96%, and 34.31% [2] - Tianyu Biological is classified under the Shenwan industry as agriculture, forestry, animal husbandry, and fishery - pig farming, and is associated with concepts such as pork, characteristic towns, ecological landscaping, energy conservation and environmental protection, and micro-cap stocks [2] Financial Performance - As of June 30, the number of shareholders for Tianyu Biological is 20,200, a decrease of 2.00% from the previous period, with an average of 14,363 circulating shares per person, an increase of 2.04% [2] - For the first half of 2025, the company achieved operating revenue of 412 million yuan, a year-on-year decrease of 2.62%, while the net profit attributable to the parent company was 10.82 million yuan, a year-on-year increase of 73.68% [2] Stock Performance - On September 30, Tianyu Biological's stock price increased by 2.03%, reaching 9.05 yuan per share, with a trading volume of 35.16 million yuan and a turnover rate of 1.36%, resulting in a total market value of 2.626 billion yuan [1] - Year-to-date, the stock price has risen by 12.42%, with a 2.72% increase over the last five trading days, a 10.37% increase over the last 20 days, and a 21.31% increase over the last 60 days [1] - The company has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on September 16, where the net buying on that day was 1.1632 million yuan, with total buying of 86.5781 million yuan, accounting for 16.99% of total trading volume, and total selling of 85.4149 million yuan, accounting for 16.76% of total trading volume [1] Dividend Information - Since its A-share listing, Tianyu Biological has distributed a total of 34.54 million yuan in dividends, with no dividends distributed in the last three years [3]

证券代码：603717 证券简称：天域生物 公告编号：2025-088 天域生物科技股份有限公司 关于股东回馈活动的自愿性信息披露公告 三、报名条件 本次活动期间持有过"天域生物"股票的投资者且个人交易账号可以在同花 顺 App 登录。 四、活动形式 1、进入天域生物股东节专场活动页：同花顺 App 搜索"股东节"或扫描下 方二维码； 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 天域生物科技股份有限公司（以下简称"公司"、"天域生物"）为建立长 效、多样的股东回报机制，感谢广大股东长期以来对公司的关注和支持，同时让 股东更好地了解和体验公司产品，提高股东对公司内在价值的理解和认识，公司 将联合浙江核新同花顺网络信息股份有限公司（以下简称"同花顺"）开展"上 市公司股东节"股东回馈活动。现将本次活动内容公告如下： 一、活动时间 2025 年 09 月 29 日起至 2025 年 10 月 17 日 17:00 止。 二、奖品信息 一等奖：临江仙红曲酒 2 瓶、红曲丹参三七软胶囊 4 瓶/组、佳成红曲茶 2 盒/提；二等奖：满 ...

Core Insights - The aquaculture sector saw a slight increase of 0.14% on September 29, with Tianyu Biological leading the gains [1] - The Shanghai Composite Index closed at 3862.53, up 0.9%, while the Shenzhen Component Index closed at 13479.43, up 2.05% [1] Aquaculture Sector Performance - Tianyu Biological (603717) closed at 8.87, up 1.49% with a trading volume of 107,100 shares and a transaction value of 93.82 million yuan [1] - Huaying Agriculture (002321) closed at 2.98, up 1.36% with a trading volume of 583,200 shares and a transaction value of 172 million yuan [1] - Luoniushan (000735) closed at 6.36, up 1.27% with a trading volume of 182,200 shares and a transaction value of 115 million yuan [1] - Other notable performers include Shengnong Development (002299) at 17.72 (+1.14%), New Hope (000876) at 9.84 (+1.03%), and Muyuan Foods (002714) at 53.00 (+1.01%) [1] Capital Flow Analysis - The aquaculture sector experienced a net outflow of 265 million yuan from institutional investors, while retail investors saw a net inflow of 1.91 million yuan [2] - Notable net inflows from retail investors were observed in New Hope (000876) with 7.82 million yuan and Huaying Agriculture (002321) with 6.16 million yuan [3] - Conversely, Wens Foodstuffs (300498) faced a significant net outflow of 39.40 million yuan from institutional investors [3]

Core Viewpoint - The company is initiating a shareholder return activity in collaboration with Zhejiang Hexin Tonghuashun Network Information Co., Ltd. to express gratitude to shareholders for their long-term support [1] Group 1: Shareholder Return Activity - The activity is named "Listed Company Shareholder Festival" and will take place from September 29, 2025, to October 17, 2025, at 17:00 [1] - Prizes for the event include products such as Lingjiangxian Red Yeast Rice Wine, Red Yeast Dan Shen Sanqi Soft Capsules, Jiacheng Red Yeast Tea, and Manjianghong Red Yeast Rice Wine [1]

Core Points - Tianyu Biotechnology Co., Ltd. has announced the cancellation of its supervisory board and adjustments to its board of directors, including a reduction in the number of directors and the elimination of the vice chairman position [1][3] - The company will revise its articles of association and related governance systems to reflect these changes [1][4] Group 1: Cancellation of Supervisory Board - The supervisory board will be abolished, and its functions will be transferred to the audit committee of the board of directors, ensuring that the internal supervision mechanism remains operational [1] - The rules governing the supervisory board will be abolished, and any references to the supervisory board in the company's regulations will no longer apply [2] Group 2: Adjustment of Board of Directors - The number of directors on the board will be reduced from 9 to 7, with non-independent directors decreasing from 6 to 4, while the number of independent directors will remain at 3 [3] - The position of vice chairman will no longer be established [3] Group 3: Revision of Articles of Association - The company will amend certain provisions in its articles of association to align with the cancellation of the supervisory board and the adjustments to the board of directors [4]

天域生物科技股份有限公司 | 第一章 | 总则 2 | | --- | --- | | 第二章 | 经营宗旨和范围 3 | | 第三章 | 股份 3 | | 第一节 | 股份发行 3 | | 第二节 | 股份增减和回购 5 | | 第三节 | 股份转让 6 | | 第四章 | 股东和股东会 7 | | 第一节 | 股东的一般规定 7 | | 第二节 | 控股股东和实际控制人 9 | | 第三节 | 股东会的一般规定 10 | | 第四节 | 股东会的召集 14 | | 第五节 | 股东会的提案与通知 15 | | 第六节 | 股东会的召开 17 | | 第七节 | 股东会的表决和决议 19 | | 第五章 | 董事和董事会 25 | | 第一节 | 董事的一般规定 25 | | 第二节 | 董事会 28 | | 第三节 | 独立董事 31 | | 第四节 | 董事会专门委员会 34 | | 第六章 | 高级管理人员 35 | | 第七章 | 财务会计制度、利润分配和审计 37 | | 第一节 | 财务会计制度 37 | | 第二节 | 利润分配 38 | | 第三节 | 内部审计 41 | | 第四节 | 会 ...

天域生物科技股份有限公司 股东会议事规则 （2025 年 09 月修订） 第一章 总则 第一条 为提高天域生物科技股份有限公司（以下称"公司"） 股东会议事效率，保证股东会会议程序及决议的合法性，充分维护全 体股东的合法权益，根据《中华人民共和国公司法》（以下称"《公司 法》"）、《上市公司股东会规则》、《上海证券交易所股票上市规则》 等有关法律、法规、规章和规范性文件以及《天域生物科技股份有限 公司章程》（以下称"《公司章程》"）的规定，制定本议事规则（以 下称"本规则"）。 第二条 公司股东会是公司的最高权力机构，应在第一条规定的 法律、法规、规范性文件、《公司章程》及本规则规定的职权范围内 行使职权。 第三条 公司董事会应当切实履行职责，认真、按时组织股东会。 公司全体董事应当勤勉尽责，确保股东会正常召开和依法行使职权。 第四条 股东会分为年度股东会和临时股东会。年度股东会每年 召开一次，应当于上一会计年度结束后的 6 个月内举行。临时股东会 不定期召开，出现《公司法》第一百一十三条规定的应当召开临时股 东会的情形时，临时股东会应当在 2 个月内召开。 1 公司在上述期限内不能召开股东会的，应当报告公司 ...